BioCentury
ARTICLE | Clinical News

Xeglyze: Phase III data

October 13, 2014 7:00 AM UTC

Data from a pair of identical, double-blind, U.S. Phase III trials in a total of 704 patients aged 6 months and older with an active head lice infestation showed that a single topical treatment of 0.7...